as on November 6, 2025 at 2:26 am IST
Day's Low
Day's High
8.38%
Downside
7.19%
Upside
52 Week's Low
52 Week's High
43.11%
Downside
369.46%
Upside
Check China Sxt Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$163.6M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-22.50%
Compare market cap, revenue, PE, and other key metrics of China Sxt Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $163.6M | -99.97% | NA | -189.77% | |
| BUY | $18.8B | NA | 16.59 | 40.65% | |
| BUY | $41.8B | NA | 21.32 | 13.81% | |
| BUY | $14.2B | 42.73% | 33.88 | 15.95% | |
| BUY | $64.0B | -27.17% | 24.89 | 27.83% |
The China Sxt Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
China Sxt Pharmaceuticals Inc investment value today
Current value as on today
₹46,688
Returns
Returns from China Sxt Pharmaceuticals Inc Stock
Dollar Returns*
₹5,351 (+5.35%)
Search interest for China Sxt Pharmaceuticals Inc Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, SXTC stock has moved up by 4.4%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 414.74K → 455.70K (in $), with an average increase of 4.5% per quarter
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 17.5% return, outperforming this stock by 116.4%
Against Peers
![]()
In the last 1 year, Neurocrine Biosciences Inc. has given 14.3% return, outperforming this stock by 76.0%
Profit Down
![]()
Netprofit is down for the last 4 quarters, 3.29M → -1.25M (in $), with an average decrease of 107.9% per quarter
| Organisation | China Sxt Pharmaceuticals Inc |
| Headquarters | 178 Taidong Road North, Taizhou, China, 225300 |
| Industry | Health Technology |
| CEO | Mr. Feng Zhou |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Sze Beng Lim | Co-Chief Executive Officer |
Mr. Xiaodong Pan | Chief Financial Officer |
Mr. Jun Zheng | Executive Director |
Mr. Feng Zhou | Chairman of the Board & Co-CEO |
China Sxt Pharmaceuticals Inc share price today is $1.67 as on at the close of the market. China Sxt Pharmaceuticals Inc share today touched a day high of $1.79 and a low of $1.53.
China Sxt Pharmaceuticals Inc share touched a 52 week high of $7.84 on and a 52 week low of $0.95 on . China Sxt Pharmaceuticals Inc stock price today i.e. is closed at $1.67,which is 78.70% down from its 52 week high and 75.79% up from its 52 week low.
China Sxt Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in China Sxt Pharmaceuticals Inc (SXTC) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in China Sxt Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on China Sxt Pharmaceuticals Inc share’s latest price of $1.67 as on November 6, 2025 at 2:26 am IST, you will get 5.9880 shares of China Sxt Pharmaceuticals Inc. Learn more about
fractional shares .
China Sxt Pharmaceuticals Inc stock has given -99.97% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?